Cas:78582-17-9 (2R,3S,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-2-(hydroxymethyl)oxolan-3-ol manufacturer & supplier

We serve Chemical Name:(2R,3S,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-2-(hydroxymethyl)oxolan-3-ol CAS:78582-17-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(2R,3S,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-2-(hydroxymethyl)oxolan-3-ol

Chemical Name:(2R,3S,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-2-(hydroxymethyl)oxolan-3-ol
CAS.NO:78582-17-9
Synonyms:3-Deaza-2′-dA;7H-Pyrrolo(2,3-d)pyrimidin-4-amine, 7-(2-deoxy-β-D-erythro-pentofuranosyl)-;7H-Pyrrolo(2,3-d)pyrimidine, 4-amino-7-(2-deoxy-β-D-erythro-pentofuranosyl)-;7-(2-Deoxy-β-D-erythro-pentofuranosyl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine;3-deaza-2′-deoxyadenosine;2′-Deoxy-3-deazaadenosine;7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 7-(2-deoxy-β-D-erythro-pentofuranosyl)-;7-(2-Deoxy-β-D-erythro-pentofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Molecular Formula:C11H14N4O3
Molecular Weight:250.254
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:601.3±55.0 °C at 760 mmHg
Density:1.8±0.1 g/cm3
Index of Refraction:1.797
PSA:106.42000
Exact Mass:250.106583
LogP:-0.06

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-Deaza-2′-dA chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,7-(2-Deoxy-β-D-erythro-pentofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 7-(2-deoxy-β-D-erythro-pentofuranosyl)- Use and application,7-(2-Deoxy-β-D-erythro-pentofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine technical grade,usp/ep/jp grade.


Related News: In Massachusetts, where the bulk of Takeda’s U.S. operations are based since the Shire buyout, the Japanese pharma has been swiftly ramping up its cell therapy ambitions. In September, the company cut the ribbon on a new 24,000-square-foot R&D manufacturing center in Boston, which it said at the time would handle clinical development for three ongoing pipeline programs and two other prospects pegged to enter clinical development by the end of 2021. trichloro-methanesulfenic acid-[2]naphthyl ester manufacturers Global Empowerment Mission, in phase three of the rehabilitation efforts for those who lost everything is partnering with The Shul of Bal Harbour, and funding partners EZS Events, Ygrene, and Hatzalah of South Florida to provide aid in the form of first and last month payments as well as security deposits on annual leases. 3-(5-trichloromethyl-[1,2,4]oxadiazol-3-yl)-pyridine suppliers As the Covid-19 pandemic continues to challenge the global drug supply chain, nations are looking for new ways to enable native producers to continue scaling up. Now, an Israeli API maker is dropping a down payment into an Indian intermediates company to ramp up its own manufacturing base. N-(1-benzylpiperidin-4-yl)-4-(3,5-diethyl-1H-pyrazol-1-yl)benzamide vendor & factory.